Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
25.36
-0.02 (-0.08%)
Aug 10, 2026, 11:42 AM EDT - Market open
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $420.23 million as of August 10, 2026. Its market cap has increased by 517.77% in one year.
Market Cap
420.23M
Enterprise Value
231.30M
1-Year Change
517.77%
Ranking
Category
Stock Price
$25.36
ChartMarket Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has increased from $346.92M to $420.23M, an increase of 21.13%. That is a compound annual growth rate of 2.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 420.23M | 326.33% |
| Dec 31, 2025 | 98.57M | -35.03% |
| Dec 31, 2024 | 151.72M | -41.98% |
| Dec 29, 2023 | 261.49M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -30.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 443.40M |
| Editas Medicine | 442.31M |
| vTv Therapeutics | 438.92M |
| Larimar Therapeutics | 434.23M |
| Ocugen | 434.06M |
| SL Science Holding | 431.54M |
| Atea Pharmaceuticals | 420.14M |
| Abeona Therapeutics | 412.64M |